Ballard to launch FCmove®-SC fuel cell at Busworld: improved performance and lifecycle cost on the road to diesel parity
New fuel cell engineered to power city transit buses – lower cost, simplified vehicle integration, smarter fleet services, and enhanced safety VANCOUVER, BC, Sept. 17, 2025 /PRNewswire/ – Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) will unveil its new-generation transit fuel cell module, the FCmove®-SC, at Busworld in Brussels on 4–9 October 2025. Designed for […]
WESTLAWN AMERICAS OFFSHORE ANNOUNCES NEW COUNTRY ENTRY WITH ACQUISITION OF WORKING INTEREST IN Z-61, Z-62, AND Z-63 BLOCKS OFFSHORE PERU
HOUSTON, Sept. 17, 2025 /PRNewswire/ — Westlawn Americas Offshore LLC (“WAO”), a portfolio company of the Westlawn Group (“Westlawn”), is pleased to announce the completion of a transaction in which it has acquired a 30% non-operated working interest in the Z-61, Z-62, and Z-63 blocks offshore Peru (the “Transaction”). The working interest was acquired pursuant […]
Bullish Reports Second Quarter 2025 Results
Bullish obtains New York DFS BitLicense, unlocking Q4’2025 US market entry Q2’2025 Digital asset sales of $58.6 billion and net income of $108.3 million Q2’2025 Adjusted Revenue of $57.0 million and Adjusted EBITDA of $8.1 million Q3’2025 Adjusted Revenue Guidance of $69.0 to $76.0 million and Adjusted EBITDA of $25.0 to $28.0 million CAYMAN ISLANDS, […]
LNTH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Sept. 17, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), have until November 10, 2025 to seek appointment as lead plaintiff of […]
M&T Bank Corporation Announces Third Quarter 2025 Earnings Release and Conference Call
BUFFALO, N.Y., Sept. 17, 2025 /PRNewswire/ — M&T Bank Corporation (“M&T”) (NYSE:MTB) plans to announce its third quarter 2025 earnings results in a press release that will be issued before the market opens on Thursday, October 16, 2025. Following the release, M&T will conduct a conference call and webcast at 11:00 a.m. (ET) to discuss […]
Ontario International Airport soars to #2 in J.D. Power’s 2025 North America Airport Satisfaction Study
ONTARIO, Calif., Sept. 17, 2025 /PRNewswire/ — Ontario International Airport (ONT) has climbed to new heights in the latest J.D. Power North America Airport Satisfaction StudySM, ranking No. 2 among all medium-sized airports in North America. The Southern California gateway advanced from fourth place in 2024, further cementing its reputation as one of the nation’s most passenger-friendly airports. Continue […]
EADV Congress 2025: GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
PARIS, Sept. 18, 2025 /PRNewswire/ — Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown. The study – the largest of its kind and presented today […]
Congrès EADV 2025 : Les médicaments GLP-1RA réduisent considérablement la mortalité et le risque cardiovasculaire chez les patients atteints de psoriasis
PARIS, 18 septembre 2025 /PRNewswire/ — Les patients atteints de psoriasis traités par des agonistes du récepteur du peptide-1 de type glucagon (GLP-1RA) présentent un risque de décès réduit de 78 % et un risque d’événements cardiovasculaires majeurs réduit de 44 % par rapport à ceux qui prennent d’autres médicaments contre le diabète ou pour […]
Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes
In SURPASS-PEDS, Mounjaro met the primary and all key secondary endpoints at 30 weeks and showed sustained improvement in glycemic control and continued BMI reduction through the study’s 52-week extension The safety and tolerability profile of Mounjaro was generally consistent with previous adult studies INDIANAPOLIS, Sept. 17, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: […]
DOW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
SAN DIEGO, Sept. 17, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Dow Inc. (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, October 28, 2025 to seek appointment as lead plaintiff of the Dow class action lawsuit. […]